Navigation Links
Microfluidic devices advance 3-D tissue engineering at Stevens

A research team, co-headed by Dr. Woo Lee and Dr. Hongjun Wang of Stevens Institute of Technology, has published a paper describing a new method that generates three-dimensional (3D) tissue models for studying bacterial infection of orthopedic implants. Dr. Joung-Hyun Lee of Stevens, and Dr. Jeffrey Kaplan of the New Jersey Dental School, are co-authors of the research. Their paper, appearing in the journal Tissue Engineering, demonstrates a physiologically relevant approach for studying infection prevention strategies and emulating antibiotic delivery using 3D bone tissues cultured in microfluidic devices.

With over 1 million hip and knee replacement procedures being performed in the United States every year, orthopedic implants have become relatively common. Despite advances in implant design, hospitals have been unable to address bacterial infection, the leading cause of failure in orthopedic implants. A significant barrier to successfully developing infection-fighting drugs or biomaterials has been the inadequacy of laboratory equipment to create clinically relevant environment with traditional in vitro methods.

The researchers seeded 0.02 mL microfluidic channels with osteoblasts and inoculated the channels with Staphylococcus epidermis bacteria, a common pathogen in orthopedic infections. Nutrient solutions were pumped through the channels at a concentration and flow rate mimicking conditions within the human body. Bone tissue cells and bacteria within the channels were imaged with a microscope and effluent was analyzed for bacteria count.

Microfluidic devices, together with finely-tuned dynamic flow settings, have the potential to provide realistic bone tissue models in clinical scenarios. As opposed to the static 2D Petri dish surfaces, microfluidic channels present a realistic environment for cells to grow and adhere in three dimensions. Dynamic fluid motion through the channelswith solutions potentially carrying antibiotics or other novel drugsfurther mimics real-world conditions previously unrealizable in a lab setting.


Contact: Dr. Woo Lee
Stevens Institute of Technology

Related biology technology :

1. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
2. GEN Reports on Growing Reliance on Microfluidics Technology
3. Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries
4. Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems
5. MicroFluidic Systems (MFSI) Receives Patent for Method to Selectively Process Different Biological Cell Types for Analysis.
6. Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization
7. Microfluidics International Corporation to Report Second Quarter 2009 Financial Results on August 11, 2009
8. Microfluidics International Corporation Announces Second Quarter 2009 Financial Results
9. Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2, 2009
10. Microfluidics International Corporation Announces Third Quarter 2009 Financial Results
11. Microfluidics Chairman James N. Little, Ph.D., Announces Retirement from Board of Directors
Post Your Comments:
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... of Black Aerospace Professionals (OPBAP) has been formalized with the signing of a ... leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and ... early in their initial angel funding process. Now, they are paying it forward ... make early stage investments in the microbiome space. In this, they join ...
(Date:11/24/2015)... Nov. 24, 2015 Cepheid (NASDAQ: CPHD ... at the following conference, and invited investors to participate ...      Tuesday, December 1, 2015 at 11.00 a.m. ...      Tuesday, December 1, 2015 at 11.00 a.m. ... New York, NY      Tuesday, December ...
Breaking Biology Technology:
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has ... of MIT and Harvard for use of its ... information management tools. The partnership will support the ... biological and chemical research information internally and with ... be used for managing the Institute,s electronic laboratory ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):